Şunu aradınız:: seropożittivi (Maltaca - İngilizce)

seropożittivi (n=506)
seropositive (n=506)

effikaċja f’pazjenti seropożittivi għall-awtoantikorpi (rf u jew anti-ccp)
efficacy in autoantibody (rf and or anti-ccp) seropositive patients

suġġetti li għall-bidu kienu seropożittivi u seronegattivi waslu biex kellhom titres bħal dawk wara l-vaċċinazzjoni.
initially seropositive and seronegative subjects reached similar titres after vaccination.

il-ħnieżer seropożittivi milli jħallu l-impriża fejn ikunu miżmuma, għajr għall-qatla minnufih;
seropositive pigs from leaving the holding where they are kept, except for immediate slaughter;

f’ġimgħa 48 pazjenti seropożittivi kienu 2-3 darbiet aktar probabbli li jiksbu risponsi acr meta mqabbel ma’ pazjenti seronegattivi.
at week 48 seropositive patients were 2-3 times more likely to achieve acr responses compared to seronegative patients.

in-nisa kollha li fil-bidu kienu seropożittivi baqgħu seropożittivi għaż-żewġ antikorpi kontra hpv-16 u hpv- 18.
all initially seropositive women remained seropositive for both anti-hpv-16 and anti-hpv-18 antibodies.

pazjenti seropożittivi kellhom wkoll tnaqqis sinifikament akbar f’das28-esr meta mqabbel ma’ pazjenti seronegattivi (figura 1).
seropositive patients also had a significantly greater decrease in das28-esr compared to seronegative patients (figure 1).

m’hemmx differenzi b’sinifikanza klinika fil-karatteristiċi farmakokinetiċi ta’ indinavir f’nisa bl-hiv seropożittivi meta mqabbla ma’ rġiel bl-hiv seropożittivi.
there are no clinically significant differences in the pharmacokinetics of indinavir in hiv seropositive women compared to hiv seropositive men.